EcoDrugPlus

Steroid 5 Alpha-Reductase 2

Ensembl ID : ENSMMNG00015016973
Gene Symbol: SRD5A2
3 Cross references
263 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSMMNG00015011479
Gene Symbol: SOAT1
3 Cross references
210 Possible Orthologues:

Sucrase-Isomaltase

Ensembl ID : ENSMMNG00015000088
Gene Symbol: SI
3 Cross references
200 Possible Orthologues:

Synuclein Alpha

Ensembl ID : ENSMMNG00015011091
Gene Symbol: SNCA
3 Cross references
188 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSMMNG00015007135
Gene Symbol: TACR1
3 Cross references
267 Possible Orthologues:

Tachykinin Receptor 2

Ensembl ID : ENSMMNG00015018482
Gene Symbol: TACR2
3 Cross references
199 Possible Orthologues:

Tachykinin Receptor 3

Ensembl ID : ENSMMNG00015009099
Gene Symbol: TACR3
3 Cross references
256 Possible Orthologues:

Telomerase Reverse Transcriptase

Ensembl ID : ENSMMNG00015005153
Gene Symbol: TERT
1 Cross references
189 Possible Orthologues:

Thromboxane A Synthase 1

Ensembl ID : ENSMMNG00015009967
Gene Symbol: TBXAS1
1 Cross references
219 Possible Orthologues:

Thromboxane A2 Receptor

Ensembl ID : ENSMMNG00015000841
Gene Symbol: TBXA2R
3 Cross references
192 Possible Orthologues:

Thymidylate Synthetase

Ensembl ID : ENSMMNG00015003074
Gene Symbol: TYMS
3 Cross references
224 Possible Orthologues:

Thyroid Hormone Receptor Beta

Ensembl ID : ENSMMNG00015011253
Gene Symbol: THRB
3 Cross references
392 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).